Determine the necessary mass, volume, or concentration for preparing a solution.
Moligand™, 10mM in DMSO Moligand™ for sensitive chromatographic and analytical workflows requiring minimal baseline interference.
Store at -80°C Ships Dry ice packs + Cold packs Check lot-specific COA for exact specifications.
SDS, COA, datasheet, and spec sheet available for download. Lot-specific COA accessible via lot number lookup.
Cited in 21 peer-reviewed publications across chromatography, organic synthesis, and cross-coupling reactions.
Information
Tigecycline (GAR-936) is bacteriostatic and is a protein synthesis inhibitor by binding to the 30S ribosomal subunit of bacteria and thereby blocking entry of Aminoacyl-tRNA into the A site of the ribosome during prokaryotic translation. Tigecycline induc
In vitro
Tigecycline evades the Tet(A-E) efflux pumps, which account for most acquired resistance to tetracycline and minocycline in Enterobacteriaceae and Acinetobacter spp. Tigecycline binds to bacterial ribosomes that have been modified by the Tet(M) protein, a mechanism that compromises all available tetracyclines, and which is frequent in Gram-positive cocci and Neisseria spp. Tigecycline remains vulnerable to the chromosomally-encoded multidrug efflux pumps of Proteeae and Pseudomonas aeruginosa, and to Tet(X), a tetracycline-degrading mono-oxygenase found, albeit rarely, in Bacteroides spp. Tigecycline MICs for enterococci, staphylococci, and streptococci are mostly 0.06–0.25 mg/L, again with little or no skew to the distribution. Tigecycline is prone to oxidation, and MIC values, particularly for the most susceptible isolates, may be raised if the drug is added to broth that has become oxygenated during storage, or if drug-containing media are stored before inoculation. Tigecycline is a poor substrate for tetracycline-specific efflux pumps, and it still attaches to ribosomes that have been modified by the Tet(M) protein. Tigecycline has demonstrated activity against a wide variety of gram-positive and gram-negative pathogens, including multidrug-resistant strains. Tigecycline is active against many gram-positive and -negative organisms, including methicillin-resistantStaphylococcus aureus, vancomycin-intermediate and -resistant enterococci, and extended-spectrum β-lactamase–producing\xa0Escherichia coli\xa0and\xa0Klebsiella pneumoniae.\xa0Tigecycline exhibits antibacterial activity against a wide spectrum of aerobic and anaerobic bacteria. Tigecycline is a broad-spectrum, protein-inhibiting, antibacterial agent possessing activity against strains resistant to other chemotherapeutic agents. Tigecycline demonstrates in vitro activities against the GISA and the methicillin-resistant and methicillin-susceptible staphylococcal strains tested (MICs at which 90% of isolates tested are inhibited [MIC90s], 0.5 to 1 μg/ml). Tigecycline has MIC90s of 0.25 μg/ml for all of the S. pneumoniae strains and demonstrates similar activities against all of the S. pneumoniae strains tested.
In vivo
Tigecycline is bactericidal against methicillin-susceptible S. aureus (MSSA) in the rabbit osteomyelitis model and exhibits good, but not excellent, activity in Legionellapneumophila pneumonia in guinea pigs. Tigecycline at 50 mg/kg twice daily was not toxic to mice. Tigecycline is effective in inhibiting NSCLC growth in vivo through decreasing proliferation and increasing apoptosis of tumor cells.
Cell Data
cell lines:HCT116, HCA7, Caco2 and NCI-H716 cells
Concentrations:1, 5, 10, 25, 50 μM
Incubation Time:24 h or 3 days
Powder Purity:≥96%
| ALogP | 1.1 |
|---|
| Isómeros SMILES | CC(C)(C)NCC(=O)NC1=CC(=C2C[C@H]3C[C@H]4[C@@H](C(=O)C(=C([C@]4(C(=O)C3=C(C2=C1O)O)O)O)C(=O)N)N(C)C)N(C)C |
|---|---|
| Peso molecular | 585.65 |
| Reaxy-Rn | 35955618 |
| Reaxys-RN_link_address | https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN=35955618&ln= |
Comprehensive hazard, handling, storage, and regulatory compliance document.
Download SDS →Lot-specific quality data. Enter your lot number to retrieve the exact COA.
Look up COA →Full quality attributes and acceptance criteria for this grade.
View spec sheet →| Rotación específica [α] | -199° (C=0.15,CH3OH) |
|---|---|
| Punto de fusión (°C) | 185 °C(dec.) |
| 1. Lingling Rong, Baoyin Zhang, Hongmu Qiu, Hailin Zhang, Jiayin Yu, Qing Yuan, Ligui Wu, Hong Chen, Yuanmin Mo, Xiaoming Zou, Xubiao Luo. (2025) Significant generational effects of tetracyclines upon the promoting plasmid-mediated conjugative transfer between typical wastewater bacteria and its mechanisms. WATER RESEARCH, [PMID:40749598] [10.1016/j.watres.2025.124290] |
| 2. Lin-Song Teng, Zhen-Dong Ying, Xiao-Han Sun, Hao-Cheng Hou, Shi-Dong Qiu, Peng Liu, Ke-Jing Li, Lei Zhang, Xie-Huang Sheng. (2025) Formoterol, a clinically approved drug, inhibits ferroptosis by suppressing lipid peroxidation and attenuates APAP-induced acute liver injury. CHEMICO-BIOLOGICAL INTERACTIONS, [PMID:40914538] [10.1016/j.cbi.2025.111724] |
| 3. Lingling Rong, Ligui Wu, Tiao Zhang, Cui Hu, Haihui Tang, Hongcheng Pan, Xiaoming Zou. (2023) Significant Differences in the Effects of Nitrogen Doping on Pristine Biochar and Graphene-like Biochar for the Adsorption of Tetracycline. MOLECULES, 29 (1): (173). [PMID:38202756] [10.3390/molecules29010173] |
| 4. Shunlan Li, Dongdong Chen, Ziqing Liu, Shipin Tao, Tianyi Zhang, Yiwen Chen, Lingzhi Bao, Jie Ma, Yuee Huang, Shengmin Xu, Lijun Wu, Shaopeng Chen. (2023) Directed evolution of TetR for constructing sensitive and broad-spectrum tetracycline antibiotics whole-cell biosensor. JOURNAL OF HAZARDOUS MATERIALS, [PMID:37633019] [10.1016/j.jhazmat.2023.132311] |
| 5. Xinyi Liao, Chen Chen, Zhijie Liang, Zhiwei Zhao, Fuyi Cui. (2022) Selective adsorption of antibiotics on manganese oxide-loaded biochar and mechanism based on quantitative structure–property relationship model. BIORESOURCE TECHNOLOGY, [PMID:36343776] [10.1016/j.biortech.2022.128262] |
| 6. Wang Xiaojuan, Xu Xiaoling, Zhang Shaojun, Chen Na, Sun Yunfeng, Ma Kuifen, Hong Dongsheng, Li Lu, Du Yongzhong, Lu Xiaoyang, Jiang Saiping. (2022) TPGS-based and S-thanatin functionalized nanorods for overcoming drug resistance in Klebsiella pneumonia. Nature Communications, 13 (1): (1-17). [PMID:35768446] [10.1038/s41467-022-31500-3] |
| 7. Guiqiu Li, Ying Wei, Yan Guo, Hui Gong, Jie Lian, Guangjian Xu, Bing Bai, Zhijian Yu, Qiwen Deng. (2022) Omadacycline Efficacy against Streptococcus Agalactiae Isolated in China: Correlation between Resistance and Virulence Gene and Biofilm Formation. Computational Intelligence and Neuroscience, [PMID:35510054] [10.1155/2022/7636983] |
| 8. Rouying Cai, Chenfang Miao, Liang Zhang, Yi Zhou, Yuebin Liu, Chen Zheng, Wendi Han, Zhengjun Huang, Xin Zhou, Shaohuang Weng. (2022) Determination and the pharmacokinetic study of tigecycline by fluorescence strategy with F, N codoping carbon dots as probe. SENSORS AND ACTUATORS B-CHEMICAL, [PMID:] [10.1016/j.snb.2022.131721] |
| 9. Jin-xin Zheng, Zhi-wei Lin, Xiang Sun, Wei-hong Lin, Zhong Chen, Yang Wu, Guo-bin Qi, Qi-wen Deng, Di Qu, Zhi-jian Yu. (2018) Overexpression of OqxAB and MacAB efflux pumps contributes to eravacycline resistance and heteroresistance in clinical isolates of Klebsiella pneumoniae. Emerging Microbes & Infections, [PMID:30068997] [10.1038/s41426-018-0141-y] |
| 10. Xiaodan Zheng, Menglin Wang, Shiqi Zhang, Zhima Yangcuo, Lifang He, Lingfang Xie, Yurou Ye, Guifen Xu, Zhonghui Chen, Qihong Cai. (2024) Development of a new synchronous fluorescence spectrometry combined with Al3+ sensitized for simultaneous and rapid determination of trace flumequine, ciprofloxacin and doxycycline hydrochloride residues in wastewater. WATER RESEARCH, [PMID:38908313] [10.1016/j.watres.2024.121941] |
| 11. Lei Xu, Yaling Wang, Sangyu Hu, Yuzhu Pei, Chenliang Qian, Wenjie Xue, Gao Zhang, Song Wu, Xinxin Si, Xuming Deng, Jie Xia, Jianfeng Wang. (2025) Discovery of Metabolic Reprogramming 2-Quinolones as Effective Antimicrobials for MRSA-Infected Wound Therapy. JOURNAL OF MEDICINAL CHEMISTRY, [PMID:39869779] [10.1021/acs.jmedchem.4c02185] |
| 12. Ruoyi Li, Muchen Lu, Jiaqi Yu, Jian Zhang, Jia Li, Xinyan Wang. (2025) Efficient electrocatalytic degradation of tigecycline by copper foam-supported Pd-ZnS dual nanoparticle structures: A study of H* reduction and mechanism of action. PROCESS SAFETY AND ENVIRONMENTAL PROTECTION, [PMID:] [10.1016/j.psep.2025.107019] |
| 13. Haina Bai, Jian Zhang, Shipeng Li, Muchen Lu, Jia Li, Ruoyi Li. (2024) Electrocatalytic study on the degradation of tigecycline wastewater using a three-dimensional porous agarose@MXene hydrogel carbon cloth electrode with high conductivity. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, [PMID:39626821] [10.1016/j.ijbiomac.2024.138231] |
| 14. Yuwei Zheng, Jiaying Chi, Jiayu Ou, Ling Jiang, Liqing Wang, Rui Luo, Yilang Yan, Zejun Xu, Tingting Peng, Jianfeng Cai, Chuanbin Wu, Peng Teng, Guilan Quan, Chao Lu. (2024) Imidazole-Rich, Four-Armed Host-Defense Peptidomimetics as Promising Narrow-Spectrum Antibacterial Agents and Adjuvants against Pseudomonas Aeruginosa Infections. Advanced Healthcare Materials, [PMID:39039988] [10.1002/adhm.202400664] |
| 15. Lili Zheng, Yangyuan Cao, Shaohua Chen. (2024) Molecular imprinting sensors based on laser-induced graphene for tigecycline sensing. International Journal of Electrochemical Science, [PMID:] [10.1016/j.ijoes.2024.100710] |
| 16. Xiangrong Li, Jingjing Zhao, Xianfei Liu, Zhizhi Song, Wanqing Xu, Zheng Li. (2024) Probing the interaction mechanism of tigecycline with γ-globulin and hemoglobin in the absence and presence of amikacin. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, [PMID:39722387] [10.1016/j.ijbiomac.2024.139109] |
| 17. Xinxin Jiang, Jingfei Long, Yanzhen Song, Xiaoyu Qi, Ping Li, Kuiquan Pan, Chenyang Yan, Hongzhou Xu, Haixia Liu. (2024) The effect of triclosan on intergeneric horizontal transmission of plasmid-mediated tigecycline resistance gene tet(X4) from Citrobacter freundii isolated from grass carp gut. ENVIRONMENTAL POLLUTION, [PMID:38432343] [10.1016/j.envpol.2024.123658] |
| 18. Nan Guo, Sheng Hu, Yahui Zhang, Wen Zhang, Dejun Li, Yue Tang, Zijian Tai, Xin Guo, Bing Leng. (2025) Determination of Tigecycline in Plasma and Bronchoalveolar Lavage Fluid by UPLC–MS/MS and Its Application to a Pharmacokinetic Study in Critically Ill Patients. BIOMEDICAL CHROMATOGRAPHY, 39 (5): (e70055). [PMID:40207530] [10.1002/bmc.70055] |
| 19. Xiangrong Li, Xianfei Liu, Jingjing Zhao, Yujie Sun, Yuxin Liang, Qiongya Hu. (2025) Formation mechanism and antibacterial activity of natural antimicrobial lysozyme with antibiotics doxycycline and tigecycline. JOURNAL OF MOLECULAR BIOLOGY, [PMID:40578673] [10.1016/j.jmb.2025.169304] |
| 20. Qihong Cai, Xiaodan Zheng, Sujun Fang, Qifeng Zou, Hang Zhu, Zhima Yangcuo, Yajuan Zhang, Yong Lin, Chunyan Lian, Shiqi Zhang. (2026) High sensitive and simultaneous determination of chlortetracycline hydrochloride and tetracycline hydrochloride residues in water using zero-crossing first derivative synchronous fluorescence spectrometry. PROCESS SAFETY AND ENVIRONMENTAL PROTECTION, [PMID:] [10.1016/j.psep.2026.108431] |
| 21. Chenyang Wang, Cuiyu Huang, Licheng Yu, Xiwen He, Langxing Chen, Yukui Zhang. (2026) In situ-grown ambient-temperature dual-emissive RhB/COF@ZIF-90 composite for ratiometric fluorescence detection of tetracycline in foods. FOOD CHEMISTRY, [PMID:41747548] [10.1016/j.foodchem.2026.148553] |
Our grade selection guide covers purity, stabilizer status, and application suitability for all variants in our catalog.
View Moligand™ grade guide →